Silvia Mezi

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

Chiara Cremolini, Fotios Loupakis, Carlotta Antoniotti et al. · The Lancet Oncology · 2015 · 1.1K citations · Full text

Phase 3, Gastrointestinal Oncology, Medicine +8

The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy

Andrea Botticelli, Alessio Cirillo, Simone Scagnoli et al. · Vaccines · 2020 · 63 citations · Full text

The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study

Andrea Botticelli, Ilaria Grazia Zizzari, Simone Scagnoli et al. · Journal of Personalized Medicine · 2021 · 57 citations · Full text

Tobacco, Alcohol and Family History of Cancer as Risk Factors of Oral Squamous Cell Carcinoma: Case-Control Retrospective Study

Gianluca Tenore, Alessandro Nuvoli, Ahmed Mohsen et al. · Applied Sciences · 2020 · 54 citations · Full text

Epidemiology Of Cancer, Pathology, Family History +20

Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1

Andrea Botticelli, Silvia Mezi, Giulia Pomati et al. · Frontiers in Immunology · 2020 · 46 citations · Full text